Search by Drug Name or NDC
NDC 68382-0593-01 perphenazine 8 mg/1 Details
perphenazine 8 mg/1
perphenazine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is PERPHENAZINE.
MedlinePlus Drug Summary
Perphenazine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Perphenazine is also used to control severe nausea and vomiting in adults. Perphenazine is in a class of medications called conventional antipsychotics. It works by decreasing abnormal excitement in the brain.
Related Packages: 68382-0593-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Perphenazine
Product Information
| NDC | 68382-0593 |
|---|---|
| Product ID | 68382-593_0aa00a79-3824-48b4-b106-754ce62d706f |
| Associated GPIs | 59200045000315 |
| GCN Sequence Number | 003833 |
| GCN Sequence Number Description | perphenazine TABLET 8 MG ORAL |
| HIC3 | H2G |
| HIC3 Description | ANTIPSYCHOTICS,PHENOTHIAZINES |
| GCN | 14653 |
| HICL Sequence Number | 001627 |
| HICL Sequence Number Description | PERPHENAZINE |
| Brand/Generic | Generic |
| Proprietary Name | perphenazine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | perphenazine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | PERPHENAZINE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA205232 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0593-01 (68382059301)
| NDC Package Code | 68382-593-01 |
|---|---|
| Billing NDC | 68382059301 |
| Package | 100 TABLET in 1 BOTTLE (68382-593-01) |
| Marketing Start Date | 2020-07-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.33861 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | PERPHENAZINE 8 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis